The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Carfilzomib (CFZ), carboplatin and etoposide for previously untreated extensive-stage small cell lung cancer (ES-SCLC): Phase 1b results from a phase 1b/2 study.
 
Firas Benyamine Badin
No Relationships to Disclose
 
Anne C. Chiang
Consulting or Advisory Role - Genentech; Genentech/Roche
Research Funding - Boehringer Ingelheim; Millennium; OncoMed; Onyx
 
William B. Fisher
No Relationships to Disclose
 
Sergey Orlov
No Relationships to Disclose
 
Harry D. Harper
No Relationships to Disclose
 
Elhamy Eskander
No Relationships to Disclose
 
Wael A. Harb
Consulting or Advisory Role - Onyx
Research Funding - Horizon Oncology Research
 
Ebenezer Kio
No Relationships to Disclose
 
Priya Kadambi Gopalan
Research Funding - Abbvie (Inst); Onyx (Inst)
 
Daniel Ernest Haggstrom
No Relationships to Disclose
 
Olga Burdaeva
No Relationships to Disclose
 
Anita Zahlten-Kumeli
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Sanjay Aggarwal
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Mihaela Obreja
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Vera Gorbunova
No Relationships to Disclose